Whilst the Disease Activity Scores (DAS_CRP) declined in patients with RA over the first 6 months (p = 0.032), our pilot immunological analysis revealed no changes in immunological ageing features in these patients over the first 6 months after starting DMARDs [Supplementary Table S15]. Here, CRP is linked to rheumatoid arthritis.